Cephalexin should be used with caution for patient with penicillin sensitivity. False positive urinary glucose and false positive Combs' test have been found during the treatment of Cephalexin. Patients with renal impairment should be given with caution. Pseudomembranous colitis has been reported with nearly all antibacterial agents, including cephalexin, and may range from mild to life threatening. Therefore, it is important to consider this diagnosis in patients with diarrhea subsequent to the administration of cephalexin. Prolonged use of cephalexin may result in the overgrowth of nonsusceptible organisms. Careful observation of the patients is essential. If superinfection occurs during therapy, appropriate measures should be taken.
Capsule: Serious and occasionally fatal hypersensitivity reactions (including anaphylactoid and severe cutaneous adverse reactions) have been reported in patients receiving therapy with beta-lactams. Before initiating therapy with Uphalexin Capsule, careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins, carbapenams or other beta-lactam agents. If an allergic reactions occurs, Uphalexin Capsule must be discontinued immediately and appropriate alternative therapy instituted.
Effects on Ability to Drive and Use Machine: There are no effects on ability to drive or to operate machinery.